By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Aclaris Therapeutics 

101 Lindenwood Drive
Suite 400
Malvern  Pennsylvania  19355  U.S.A.
Phone: 484-324-7933 Fax: 484-324-7949


SEARCH JOBS


Industry
Pharmaceutical






Company News
Aclaris Therapeutics' Lead Drug Candidate A-101 Achieves Statistically Significant Results In Third Phase 2 Clinical Trial For Seborrheic Keratosis, A Common Type Of Benign Skin Tumor 3/17/2015 9:47:56 AM
Aclaris Therapeutics Announces Positive Results From Phase 2b Clinical Trial Of A-101 For The Removal Of Seborrheic Keratosis, A Common Type Of Benign Skin Tumor 1/27/2015 6:38:13 AM
Aclaris Therapeutics Locks In $21 Million Series B Financing 10/2/2014 10:47:06 AM
Aclaris Therapeutics Announces Positive Results From Phase 2 Clinical Trial Of A-101 For The Removal Of Seborrheic Keratosis, A Common Type Of Skin Tumor 6/30/2014 10:32:08 AM
Aclaris Therapeutics Announces Positive Results From Phase 2 Clinical Trial Of A-101 For The Removal Of Seborrheic Keratosis, A Common Type Of Skin Tumor 6/30/2014 8:35:55 AM
Aclaris Therapeutics Initiates IND-Directed Program for A-101 for the Treatment of Seborrheic Keratosis, Common Type of Skin Tumor 11/6/2013 10:15:43 AM
//-->